NuVasive, Inc. was the subject of a securities class action settlement covering investors who purchased NuVasive stock during the period from October 22, 2008 through July 30, 2013. The $7.9 million total settlement fund was established to compensate eligible shareholders who experienced losses. The claim deadline has passed, but this record is maintained for investor reference.